SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-009762
Filing Date
2023-03-24
Accepted
2023-03-24 16:50:47
Documents
73
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K inkt-20221231.htm   iXBRL 10-K 2564880
2 EX-10.18 inkt-ex10_18.htm EX-10 211945
3 EX-21.1 inkt-ex21_1.htm EX-21 8431
4 EX-23.1 inkt-ex23_1.htm EX-23 3858
5 EX-31.1 inkt-ex31_1.htm EX-31 20344
6 EX-31.2 inkt-ex31_2.htm EX-31 20311
7 EX-32.1 inkt-ex32_1.htm EX-32 11821
8 EX-32.2 inkt-ex32_2.htm EX-32 11784
9 GRAPHIC img206046172_0.jpg GRAPHIC 30244
10 GRAPHIC img206046172_1.jpg GRAPHIC 37558
11 GRAPHIC img206046172_2.jpg GRAPHIC 47334
12 GRAPHIC img206046172_3.jpg GRAPHIC 26670
  Complete submission text file 0000950170-23-009762.txt   8011317

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inkt-20221231.xsd EX-101.SCH 42754
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inkt-20221231_def.xml EX-101.DEF 140313
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inkt-20221231_cal.xml EX-101.CAL 40502
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inkt-20221231_pre.xml EX-101.PRE 280896
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inkt-20221231_lab.xml EX-101.LAB 400741
67 EXTRACTED XBRL INSTANCE DOCUMENT inkt-20221231_htm.xml XML 1016625
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Filer) CIK: 0001840229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40908 | Film No.: 23760539
SIC: 2836 Biological Products, (No Diagnostic Substances)